Comparative full length genome sequence analysis of usutu virus isolates from Africa
© Nikolay et al.; licensee BioMed Central Ltd. 2013
Received: 9 March 2013
Accepted: 4 June 2013
Published: 1 July 2013
Skip to main content
© Nikolay et al.; licensee BioMed Central Ltd. 2013
Received: 9 March 2013
Accepted: 4 June 2013
Published: 1 July 2013
Usutu virus (USUV), a flavivirus belonging to the Japanese encephalitis serocomplex, was identified in South Africa in 1959 and reported for the first time in Europe in 2001. To date, full length genome sequences have been available only for the reference strain from South Africa and a single isolate from each of Austria, Hungary, and Italy.
We sequenced four USUV isolates from Senegal and the Central African Republic (CAR) between 1974 and 2007 and compared the sequence data to USUV strains from Austria, Hungary, Italy, and South Africa using a Bayesian Markov chain Monte Carlo method. We further clarified the taxonomic status of a USUV strain isolated in CAR in 1969 and proposed earlier as a subtype of USUV due to an asymetric serological cross-reactivity with USUV reference strain.
A comparison of the four newly obtained USUV sequences with those from SouthAfrica_1959, Vienna_2001, Budapest_2005, and Italy_2009 revealed that they are all 96-99% and 99% similar at the nucleotide and amino acid levels, respectively. The phylogenetic relationships between these sequences indicated that a strain isolated in Senegal in 1993 is most closely related to the USUV strains detected in Europe. Analysis of a strain isolated from a human in CAR in 1981 (CAR_1981) revealed the presence of specific amino acid substitutions and a deletion in the 3′ noncoding region. This is the first fully sequenced human USUV isolate.
The putative USUV subtype, CAR_1969, was 81% and 94% identical at the nucleotide and amino acid levels, respectively, compared to the other USUV strains. Our phylogenetic analyses support the serological identification of CAR_1969 as a subtype of USUV.
In this study, we investigate the genetic diversity of USUV in Africa and the phylogenetic relationship of isolates from Africa and Europe for the first time. The results suggest a low genetic diversity within USUV, the existence of a distinct USUV subtype strain, and support the hypothesis that USUV was introduced to Europe from Africa. Further sequencing and analysis of USUV isolates from other African countries would contribute to a better understanding of its genetic diversity and geographic distribution.
Usutu virus (USUV) is a member of the Japanese encephalitis serocomplex of flaviviruses that was isolated for the first time in 1959 in South Africa [1, 2]. Since that time, USUV has been reported in several African countries  and was recognized for the first time in Europe in 2001 in association with the deaths of blackbirds (Turdus merula) and great grey owls (Strix nebulosa) in Austria . Recently, USUV was identified in frozen samples from dead birds found in Italy in 1996, suggesting that an unrecognized introduction of USUV in Europe occurred prior to 2001 . USUV has now been reported in several European countries and is thought to have established a transmission cycle involving local bird and mosquito species , similar to that suspected in Africa [7–15]. Although the natural transmission cycle of USUV involves mosquitoes primarily of the Culex genus and birds, two cases of human infection have been reported in the Central African Republic (CAR) and Burkina Faso , in addition to two recent cases of neuroinvasive infections in immunocompromised patients in Italy [16, 17].
Strains used for the comparative sequence analysis
Cx. gr. univittatus
In this study, we analyzed the sequences of USUV strains isolated in Senegal in 1974, 1993 and 2007 in the course of an entomological surveillance program. Additionally, as several cases of human USUV infections have been reported [4, 16, 17] but no sequencing of such strains has been done, we included an isolate from a human patient with symptoms including fever and rash from CAR in 1981. Analysis of the characteristics of the latter strain has the potential to reveal determinants of human virulence. We further investigated the taxonomic status of a serologically identified USUV subtype strain isolated in CAR in 1969  to clarify whether it should be considered a distinct subtype or a new viral species.
The full genome sequences of the USUV strains Kedougou_1974 (ArD19848), CAR_1981 (HB81P08), Barkedji_1993 (ArD101291), and Barkedji_2007 (ArD192495) were 10800–10837 nt long and contained an ORF between nt positions 97 and 10401 in reference to SouthAfrica_1959 (SAAR1776). Conserved flavivirus motifs, already identified in the USUV strains from South Africa and Austria , were also found in the four newly sequenced isolates from Africa. Additionally, putative N-glycosylation sites (Asn-Xaa-Ser/Thr) could be identified at amino acid positions 118 and 154 of the E protein and are conserved among all USUV strains.
Of special interest is the strain CAR_1981, which was isolated from a patient with fever and rash. This strain differs from all other sequenced USUV strains at amino acid positions 1299, 1977, and 2702; the two latter mutations are associated with amino acid charge changes (Figure 2). Additionally, a 16 nt deletion in the 3′ noncoding region from nucleotide positions 10494 to 10510 was unique to this strain.
Positively selected sites in the USUV ORF could not be identified and the observed low mean dN/dS value (0.04) indicates the presence of strong purifying selection throughout the genome, as noted for other vector-borne RNA viruses .
The strain CAR_1969, isolated from Cx. perfuscus mosquitoes, has been serologically identified as a USUV subtype . When using a complement fixation assay, the serum against the USUV reference strain SouthAfrica_1959 recognized SouthAfrica_1959 with a titer of 32, and the strain CAR_1969 with a titer of 8. Serum raised against CAR_1969 reacted against CAR_1969 with a titer of 64 and against SouthAfrica_1959 with a titer of 16, indicating heterogeneity and a close antigenic relationship between CAR_1969 and SouthAfrica_1959 .
Although USUV has been reported in Africa for more than 50 years, only the SouthAfrica_1959 full genome sequence was available, and the genetic diversity of USUV in Africa was undescribed. Moreover, previous sequence comparisons of the SouthAfrica_1959 strain with isolates from Austria and Hungary indicated that the emergence of USUV in Europe could not be explained by an introduction from South Africa . In this study, four USUV isolates from Senegal and CAR between 1974 and 2007 were sequenced and compared to the available full length genomes from South Africa, Austria, Hungary, and Italy. Despite their geographic distance and more than 48 years separating the dates of isolation, the genetic diversity of all USUV strains was low. The mean estimated time to MRCA of all sampled USUV strains was only 188 ybp (95% HPD = 54 to 431 ybp), a relatively recent estimate for the origin of USUV on the African continent. This is especially striking when compared to the TMRCA of yellow fever virus, for example, which has a mean estimated time to MRCA of more than 1000 ybp . It is important to note, however, that the recent time to MRCA we estimated here for USUV represents only the genetic diversity of the sampled viruses, which is both geographically and temporally limited. Therefore, the isolation and sequence analysis of additional USUV strains from distinct geographic regions in Africa is likely to extend this estimate significantly.
Barkedji_2007 is the most recently isolated USUV strain; however, the MCC phylogeny suggests that this strain may be more distantly related to Barkedji_1993 and the strains isolated in Europe 20–47 years ago, then these strains are to each other (Figure 3). Therefore, genetically diverse USUV strains appear to be circulating nearly simulateously in the same geographic region. Interestingly, the strain sampled in Barkedji in 1993 was more closely related to the European USUV strains than to any other African virus. Taking into account the eight years difference between the dates of isolation, this finding supports the hypothesis that USUV was introduced into Europe from Africa. This introduction may have occurred through one of the ornithological natural parks in Africa as the one in the northern part of Senegal where many of the birds migrating between Europe and Africa stop for days or weeks . Here, the opportunity would certainly exist for birds to become infected by circulating viruses and subsequently export them from Africa to Europe. Moreover, the limited genetic diversity of USUV in Europe might reflect a recent introduction of the virus, compared to the broader diversity observed in Africa, the likely origin of USUV. Alternatively, a narrower host or vector range in Europe could also result in the reduced genetic diversity observed. Nevertheless, three specific amino acid substitutions were observed in the isolates from Europe, which may have arisen through selection or as a result of the founder effect. Whether these mutations constitute adaptations to vector species abundant in Europe or influence the infectivity of host species remains to be investigated.
The importance of USUV as human pathogen and the mechanism of USUV virulence in people are poorly understood and only a few cases of human infection have been reported [3, 16, 17]. In this study, we sequenced a USUV strain isolated in 1981 in CAR from a patient with fever and rash . Compared to all other USUV strains, three amino acid substitutions and a 16 nt deletion in the 3′ noncoding region were detected. However, the importance of these mutations for USUV virulence or replication in humans remains unclear. The comparison of CAR_1981 to other human isolates may help to identify virulence-determining sites in humans. Interestingly, the 3′ noncoding region is important for flavivirus replication and virulence determination, as the formation of secondary structures serves as cis-acting elements during RNA transcription . The observed 16 nt deletion might alter these secondary structures and thereby influence virus infectivity in vertebrate or mosquito cells, resulting in a modified vertebrate host or vector range. These potential effects should be investigated in different cell culture systems and vector competence studies.
With the exception of CAR_1969, little genetic diversity was present between the sequenced USUV genomes. Therefore, the large number of substitutions observed in CAR_1969 may indicate that CAR_1969 should be considered a distinct viral species. Instead, we suggest that CAR_1969 should be considered a subtype of USUV, based on the genetic distance between all USUV strains including CAR_1969 (0.00-0.19 subs/site), which do not exceed those observed for other closely related viruses of the Japanese encephalitis group, namely WNV (0.00-0.22 subs/site) or JEV (0.01-0.21 subs/site). The designation of CAR_1969 as a subtype strain is further supported by the observed serological crossreactions between CAR_1969 and SouthAfrica_1959. It is important to note that the designation of viruses as distinct species is based not only on differences in genome sequence, but also differences in the biological properties or natural histories. Therefore, one can provisonnally classify CAR_1969 as an USUV subtype.
The results of this study indicate that sequence differences between strains isolated in Europe and Africa may be significant enough to reduce the accuracy of molecular diagnostic tests if not considered. Our results suggest that highly conserved regions among USUV strains suitable for primers design are found mainly in the NS5 region.
This is the first study of the genetic diversity of USUV in Africa and the phylogenetic relationships of these strains to those identified in Europe. The results suggest that limited genetic diversity is present in the sampled USUV, and further strengthens the hypothesis that USUV was introduced into Europe from Africa. However, USUV isolations in Africa have been reported primarily from entomological surveillance programs and are therefore restricted to limited geographic areas. Surveying additional African countries for USUV may expand the known range of this virus and further contribute to our understanding of the genetic diversity and patterns of spread of USUV in Africa. This additional data will also be necessary to resolve the origin and timing of the introduction of USUV to Europe from Africa.
The USUV strains sequenced in this study (Kedougou_1974, Barkedji_1993, Barkedji_2007, CAR_1969, CAR_1981) were provided by the CRORA (WHO Collaborating center for arboviruses and viral hemorrhagic fever viruses) of the Institut Pasteur de Dakar, either in lyophilized form or as brains of suckling mice intracerebrally inoculated with homogenate of ground mosquitoes (Kedougou_1974, Barkedji_1993, Barkedji_2007, CAR_1969) or human sera (CAR_1981). Information about the isolates analyzed in this study is summarized in Table 1.
The brains of suckling mice were homogenized in Leibovitz L-15 medium (GibcoBRL, Grand Island, NY, USA), centrifuged for 10 min at 8000 rpm at 4°C and the supernatants used for amplification. The lyophilized strains were suspended in L-15 medium. AP61 cells (Aedes pseudoscutellaris) were cultivated at 27°C in L-15 medium supplemented with 10% fetal bovine serum (FBS) (GibcoBRL, Grand Island, NY, USA), 10% of tryptose phophate (GibcoBRL, Grand Island, NY, USA), 1% penicillin/streptomycin (GibcoBRL, Grand Island, NY, USA) and 0.5% fungizone (GibcoBRL, Grand Island, NY, USA). Twenty five cm2 cell culture flasks (NUNC) of 80% confluent AP61 cells were inoculated with 100 μl supernatant of homogenized brains or suspension of lyophilized strains. After one hour of incubation at 27°C, 5 ml of AP61 medium supplemented with 5% FBS were added. Following an incubation at 27°C for 5 days, the infection was evaluated by immunofluorescence analysis using hyperimmue ascitic fluid specific for USUV as previously described . The cell supernatants were stored at −80°C.
Viral RNA was extracted from cell culture supernatants using the QIAamp viral RNA extraction kit (Qiagen, Heiden, Germany) following the manufacturer’s instructions. RT-PCR was performed using either the AMV reverse transcription kit (Promega, Madison, USA) in combination with reverse primers (Additional files 1 and 2) or the Superscript II kit (Invitrogen, Carlsbad USA) combined with pdN6 random primers (Roche, Mannheim, Germany) following the manufacturer’s instructions.
Amplifications were performed using the Go-Taq PCR kit (Promega, Madison, USA). The E, NS3 and NS5 regions were first amplified using flavivirus consensus primers as previously described (list of primers in Additional file 1) [21, 29–31]. To obtain the full genome sequences, primers were designed in conserved regions of the USUV genome (list of primers in Additional file 2). The 5′ noncoding region of the genome was obtained using the 5′RACE kit (Invitrogen, Carlsbad, USA) with the primers 5primeR2 and 5primeR3, or 5primeR4 and 5primeR5 following the provider’s instructions (Additional file 2).
PCR products were separated on 1% agarose gels in 1X TAE and extracted using the QIAquick Gel Extraction kit (Qiagen, Heiden, Germany) following the manufacturer’s instructions. Sequencing was performed by Beckman Coulter Genomics (Beckman Coulter Genomics, Takeley, UK).
Putative N-glycosylation sites were identified using NetNGlyc1.1 . Nucleotide and amino acid alignments of the USUV sequenced in this study with those available on GenBank were performed using ClustalW2 and modified manually (Table 1) . Similarity plots were performed using the SIMPLOTv.1.3 software and the Kimura 2-parameter model .
To estimate the strength and nature of selection on individual codons and determine the overall nature of natural selection acting on the genome of USUV, the mean ratio of nonsynonymous to synonymous nucleotide substitutions (dN/dS) per site were computed using the single-likelihood ancestor counting (SLAC) method available in the Datamonkey web interface of the HY-PHY package, in combination with a general time-reversable (GTR) model of nucleotide substitution and an input neighbor-joining tree .
Maximum likelihood trees of all available USUV E gene sequences (with and without the subtype strain) were generated using PAUP*v4.0b and the GTR model of nucleotide substitution with an among-site rate heterogeneity parameter (gamma, G) with four rate categories, as determined by Modeltest 3.7 (Ntaxa=18, Nchar=1500) [36, 37]. The clock-like behavior of each data set (with and without CAR_1969) was assessed by regressing the root-to-tip genetic distance inferred from the ML trees against time-of-sampling using the program Path-O-Gen v1.2 . A Bayesian Markov chain Monte Carlo (MCMC) phylogeny of USUV incorporating time-of-sampling was estimated using BEAST v1.7.5 . The analysis was performed using the SRD06 model of nucleotide substitution, a constant population size demographic model (the best-fit model, data not shown) and a relaxed molecular clock with an uncorrelated lognormal distribution of rates. Two independent MCMC runs were each performed for 100 million generations with subsampling every 10 000 generations. The runs were combined after removing a 10% burn-in from each. The maximum clade credibility tree was summarized using TreeAnnotator v1.7.5 available in the BEAST package.
An ML phylogeny of the complete polyprotein of USUV and representatives of all flaviviruses in the JEV group was created as above using a GTR+G model with invariant sites. The tree was rooted based on the phylogenetic position of the JEV group within the entire Flaviviridae family. A neighbor-joining bootstrap resampling analysis with 1000 replications was performed to assess nodal support using the ML substitution model.
The complete genomic sequences of strains CAR_1969, Kedougou_1974, CAR_1981, Barkedji_1993 and Barkedji_2007 were submitted to the GenBank database under the accession numbers KC754954-KC754958.
Birgit Nikolay was the awardee of a scholarship by the Austrian Federal Ministry for Science and Research (BMWF). The project was funded by Institut Pasteur de Dakar and European Union grant HEALTH.2010.2.3.3-3 Project 261391 EuroWest Nile (http://www.eurowestnile.org/).
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.